COLONEL BEAUREGARD  |  1,161 Days Lived

Colonel Beauregard (Beau), a 9-year-old, German Shepherd/Labrador mix, was diagnosed with osteosarcoma on the right front wrist (carpus) and underwent surgery to amputate the affected limb on March 31, 2021. After surgery, he received ECI®, completing the 7-week treatment without issue in May 2021.

In May 2022, Devin, Beau’s owner, said, “Beau did extraordinarily well during treatment – so much so that I got a call from the vet’s office the night of his amputation telling me he was standing upright and alert on all three [legs], just hours after surgery — apparently an uncommon feat and remarkable testament to his resilience. Beau is doing pretty well right now. He is extremely happy and tells me every day he wants to be here.”

Beau’s cancer remained in remission for 1,161 days post-diagnosis. In June 2024, a large mass was detected in his abdomen which the veterinarian suspected to be cancer and he was euthanized shortly afterward.

Overall, Colonel Beauregard enjoyed a happy, active lifestyle until 12 years of age, surviving for more than 3 years and 2 months after his cancer diagnosis.

CAVIC  |  598 Days Lived

Cavic, a 9-year-old Greyhound, was diagnosed with appendicular osteosarcoma in his left forelimb in December 2021.

“As a veterinarian, I was prepared for this diagnosis which is common in my favorite breed – greyhounds – so I acted quickly when he developed a subtle forelimb lameness,” said Dr. Rebecca Kennerly, Cavic’s owner and a veterinary cardiologist. “I knew I wanted to pursue immunotherapy with ELIAS Animal Health after reviewing the article published in the Journal of Veterinary Internal Medicine in 2020.”

Cavic underwent amputation of the affected limb that month, and completed ECI® in February 2022. Cavic’s cancer remained in remission for nearly 10 months until a single pulmonary nodule was identified on x-rays at a regularly scheduled recheck appointment. After consultation with Cavic’s oncology team, Dr. Kennerly pursued additional treatment with a combination chemotherapy.

“I was anticipating a faster decline after the diagnosis of pulmonary metastasis, but the next thing I knew I was planning his 11th birthday party!” said Dr. Kennerly. “His pulmonary nodule remained stable in size, and he lived each day to the fullest that year.”

Cavic lived an additional 598 days after his original diagnosis. In August 2023, he developed lameness in his hindlimb, and x-rays showed a new lytic lesion on his femur. “I’m so proud of my boy, and I’m so thankful for the 20 extra months of memories that his innovative care was able to give me,” said Dr. Kennerly.

Ruby

“Ruby was diagnosed with osteosarcoma in December 2016 after we noticed she was favoring her back left leg. Ruby’s veterinarian at the University of Missouri told us about the ELIAS trial and it was an obvious YES. Her care team told us Ruby tolerated the treatments well, although she was an escape artist getting out of the cone!

Today, Ruby is alive and thriving. She turned 12 in August 2020 and has more energy now than ever before. She loves to run, chase birds and rabbits, and going on walks. We recently moved from MO to MI and when it snows (which is often), she loves running in it. Ruby is a gem and we are so happy those years with her have been extended.”

–Kristen C.

Echo

“Echo was diagnosed with osteosarcoma of the left distal tibia on May 16, 2017. All the stars aligned and she was included in the clinical trial at the University of Missouri. Her left hind leg was amputated, she received three autologous vaccines and apheresis, followed by 5 doses of IL-2. In February 2019, Echo still showed no signs of metastases and we could not be more thrilled with the results of the trial.

She enjoys an active lifestyle at home with her brother (litter mate), Houdini. They both love going for car rides and running alongside the bike. Echo can easily keep up with her brother, even with one limb missing.”

–Carrie D.

Millie

“Just before her 8th birthday, Millie was diagnosed with osteosarcoma and had her front left leg amputated in February 2019. In choosing options for treatment to keep the cancer from spreading, I learned about the immunotherapy trial at ELIAS which sounded really exciting. Millie completed her treatment at the beginning of April and she sailed right through without complications or side effects.

Today, she has pretty much gotten the hang of being a “tripawd” and she’s bopping around just like she used to before her diagnosis. I am so grateful for being a part of this study and I hope this helps other pups kick this disease to live a long and happy life!”

–Maureen H.